VP of Research and Development Murali Ramachandran bought $318 worth of shares (200 units at $1.59), increasing direct ownership by 0.15% to 133,057 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

KAPA· Kairos Pharma Ltd.

Health Care

Original source

VP of Research and Development Murali Ramachandran bought $318 worth of shares (200 units at $1.59), increasing direct ownership by 0.15% to 133,057 units (SEC Form 4) | Quantisnow